Johnson & Johnson advances leadership in rheumatic disease innovation with 43 abstracts at ACR 2024

MLA

“Johnson & Johnson Advances Leadership in Rheumatic Disease Innovation with 43 Abstracts at ACR 2024.” Plus Company Updates, 8 Nov. 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.815316891&authtype=sso&custid=ns315887.

APA

Johnson & Johnson advances leadership in rheumatic disease innovation with 43 abstracts at ACR 2024. (2024, November 8). Plus Company Updates.

Chicago

Plus Company Updates. 2024. “Johnson & Johnson Advances Leadership in Rheumatic Disease Innovation with 43 Abstracts at ACR 2024,” November 8. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.815316891&authtype=sso&custid=ns315887.